Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biotech Patents Vulnerable? Court Ruling May Have Ripple Effect For Life Sciences Industry

This article was originally published in The Pink Sheet Daily

Executive Summary

Federal Circuit’s Bilski ruling could make some biotechnology patents vulnerable to infringement, industry group says.

You may also be interested in...



Patent Office Takes First Steps Toward Implementing Bilski Decision

While the Supreme Court's ruling in Bilski v. Kappos left several questions unanswered, the U.S. Patent and Trademark Office is prepared to implement the decision

Patent Office Takes First Steps Toward Implementing Bilski Decision

While the Supreme Court's ruling in Bilski v. Kappos left several questions unanswered, the U.S. Patent and Trademark Office is prepared to implement the decision

Biotech's Patent Suite Catches Sparks From Federal Circuit's Prometheus Decision

Pharmaceutical and biotech firms will have broader patent protection after an appeals court drew a narrow definition of what constitutes a natural phenomenon in the biotech arena. Specifically, the court ruled that a test to measure a drug's metabolites in order to determine the proper drug dosage is patentable subject matter

Related Content

Topics

UsernamePublicRestriction

Register

PS066999

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel